Leflutrozole

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameLeflutrozole
Drug Alias NameBGS-649RPN-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsIdiopathie hypogonadotropic hypogonadismHypogonadismEndometriosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesReproNovo SAMereo Biopharma Group PlcKanglong Chemical (Chengdu) Clinical Research Service Co Ltd
Inactive CompaniesMereo BiopharmaNovartis Pharma Ag
Active IndicationsIdiopathie hypogonadotropic hypogonadismAzoospermiaInfertility, Male +[4] 
Inactive IndicationsHypogonadismEndometriosis

Other Information

ATC CodeN/A
Related LinksN/A